Literature DB >> 31957809

C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD.

Feng-Juan Yan1, Xu Wang1, Song-En Wang1, Hai-Ting Hong1, Jun Lu1, Qin Ye1, Yuan-Lin Zheng1,2, Yong-Jian Wang1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an expanding health problem worldwide. Although many studies have made great efforts to elucidate the pathogenesis of NAFLD, the molecular basis remains poorly understood. Here, we showed that hepatic C7ORF41, a critical regulator of innate immune response, was markedly decreased in diet or genetic-induced NAFLD model. We also demonstrated that C7ORF41 overexpression significantly ameliorated hepatic inflammation and lipid accumulation in palmitic acid (PA)-treated hepatocytes, whereas C7ORF41 knockdown showed the opposite effects. Mechanistically, we found the anti-inflammatory role of C7ORF41 was attributed to the suppression of NF-κB p65-mediated induction of inflammatory cytokines. Moreover, we demonstrated that the suppression of C7ORF41 expression in hepatocytes is due to JNK activation, which promotes c-Jun-mediated transcriptional repression of C7ORF41. In conclusion, our findings suggested that a c-Jun/C7ORF41/NF-κB regulatory network controls the inflammatory response and lipid accumulation in NAFLD and may benefit the development of novel and promising therapeutic targets for NAFLD.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  C7ORF41; NF-κB; c-Jun; hepatic steatosis; inflammation

Year:  2020        PMID: 31957809     DOI: 10.1042/BCJ20190799

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease.

Authors:  Qichao Hu; Shizhang Wei; Jianxia Wen; Wenwen Zhang; Yinxiao Jiang; Caiyan Qu; Junbao Xiang; Yanling Zhao; Xi Peng; Xiao Ma
Journal:  BioData Min       Date:  2020-08-27       Impact factor: 2.522

Review 2.  Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.

Authors:  Hang-Yu Li; Ren-You Gan; Ao Shang; Qian-Qian Mao; Quan-Cai Sun; Ding-Tao Wu; Fang Geng; Xiao-Qin He; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-03-01       Impact factor: 6.543

3.  A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis.

Authors:  Jian Li; Jing Qi; Yishu Tang; Huaizheng Liu; Kefu Zhou; Zheren Dai; Lehong Yuan; Chuanzheng Sun
Journal:  J Nanobiotechnology       Date:  2021-11-17       Impact factor: 10.435

4.  Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.

Authors:  Yongxu Jia; Qian Yan; Yinli Zheng; Lei Li; Baifeng Zhang; Zhiwei Chang; Zehua Wang; Hong Tang; Yanru Qin; Xin-Yuan Guan
Journal:  J Exp Clin Cancer Res       Date:  2022-09-29

5.  Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.

Authors:  Mengyao Ma; Wenhua Xie; Xi Li
Journal:  Int J Gen Med       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.